绥美凯的推荐用量是多少呢？

It is composed of three ingredients: DTG (DTG) + Abacavir (ABC) + Lamivudine (3TC). It is a compound treatment agent of integrase inhibitors and nucleoside drugs. In 2016, GSK announced the launch of integrase DTG (Trivic) in China. This therapeutic agent has the advantages of small drug dosage, resistance to drug resistance, and low probability of drug side effects. This time, Suimeicai uses DTG, an integrase inhibitor, as the core drug, and a treatment plan with two backbone drugs, abacavir and lamivudine, and made a single-tablet treatment for promotion, making the core drug a great progress in HAART treatment. Today let’s find out what is the recommended dosage of Suimeikai?

1. Suimeikai should be taken under the guidance of a physician with experience in treating HIV infection. Adults and Adolescents (Weighing at least 40 kg) For adults and adolescents, the recommended dose is one tablet once daily.

2. If the body weight of adults or adolescents is less than 40 kg, this product should not be given because this product is a fixed-dose tablet and the dose cannot be reduced. This product is a fixed-dose tablet and should not be used in patients who require dose adjustments.

3. If it is necessary to discontinue or adjust the dosage of one of the active ingredients, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these cases, physicians should refer to the respective product information for these drugs. If a patient misses a dose of this product and it is more than 4 hours before the next dose, the patient should take this product as soon as possible.

4. If the next dose is less than 4 hours away, the patient should not take the missed dose and just resume the usual dosing schedule. 

5. Medication for children: The safety and effectiveness of Suimeikai for children under 12 years of age have not been determined. No data yet. Use in Geriatric Patients: There are limited data on the use of dolutegravir, abacavir, and lamivudine in patients 65 years and older.

6. There is no evidence that older patients require different doses than younger adult patients. Taking into account age-related changes, such as decreased renal function and changes in hematological parameters, special caution is recommended when using Suimika in this age group.

The above is the content of the dosage, I hope it can help you!